This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.
Device | P030029S002 |
Classification Name | None |
Applicant | |
PMA | P030029 |
Supplement | S002 |
Supplement Number | Date | Supplement Type |
---|---|---|
P030029 | Original Filing | |
S013 | 2012-03-26 | Normal 180 Day Track No User Fee |
S012 | 2011-02-16 | 30-day Notice |
S011 | 2010-09-29 | 30-day Notice |
S010 | ||
S009 | 2009-09-28 | Normal 180 Day Track |
S008 | 2009-08-21 | 30-day Notice |
S007 | 2009-05-18 | Normal 180 Day Track |
S006 | 2009-03-31 | Normal 180 Day Track |
S005 | 2009-03-03 | Normal 180 Day Track No User Fee |
S004 | 2008-09-18 | Normal 180 Day Track |
S003 | 2008-08-11 | Normal 180 Day Track |
S002 | ||
S001 | 2007-03-14 | 135 Review Track For 30-day Notice |
Device ID | PMA | Supp |
---|---|---|
00630414471860 | P030029 | 000 |
00630414471914 | P030029 | 003 |